Evidence map›Paper›PMID 26021331›Full record

ArticleJournal of clinical pathology2015

Assessment of tumour viability in human lung cancer xenografts with texture-based image analysis.

Riku Turkki, Nina Linder, Tanja Holopainen, Yinhai Wang, Anne Grote, Mikael Lundin, Kari Alitalo, Johan Lundin

Abstract readEvaluation Study
In one paragraph

Article in Journal of clinical pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Riku TurkkiInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Nina LinderInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Tanja HolopainenTranslational Cancer Biology Laboratory, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.
Yinhai WangInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Anne GroteInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Mikael LundinInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Kari AlitaloTranslational Cancer Biology Laboratory, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland Wihuri Research Institute, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.
Johan LundinInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland Department of Public Health Sciences, Global Health/IHCAR, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo build and evaluate an automated method for assessing tumour viability in histological tissue samples using texture features and supervised learning.

methodsH&E-stained sections (n=56) of human non-small cell lung adenocarcinoma xenografts were digitised with a whole-slide scanner. A novel image analysis method based on local binary patterns and a support vector machine classifier was trained with a set of sample regions (n=177) extracted from the whole-slide images and tested with another set of images (n=494). The extracted regions, or single-tissue entity images, were chosen to represent as pure as possible examples of three morphological tissue entities: viable tumour tissue, non-viable tumour tissue and mouse host tissue.

resultsAn agreement of 94.5% (area under the curve=0.995, kappa=0.90) was achieved to classify the single-tissue entity images in the test set (n=494) into the viable tumour and non-viable tumour tissue categories. The algorithm assigned 250 of the 252 non-viable and 219 of the 242 of viable sample regions to the correct categories, respectively. This corresponds to a sensitivity of 90.5% and specificity of 99.2%.

conclusionsThe proposed image analysis-based tumour viability assessment resulted in a high agreement with expert annotations. By providing extraction of detailed information of the tumour microenvironment, the automated method can be used in preclinical research settings. The method could also have implications in cancer diagnostics, cancer outcome prognostics and prediction.

Indexed as

AdenocarcinomaAdenocarcinoma of LungAlgorithmsAnimalsArea Under CurveArtificial IntelligenceAutomation, LaboratoryCarcinoma, Non-Small-Cell LungCell Line, TumorCell SurvivalHeterograftsHumansImage Interpretation, Computer-AssistedLung NeoplasmsMiceMice, Inbred BALB CAUTOMATED SCREENINGDIGITAL PATHOLOGYIMAGE ANALYSISLUNG CANCERtumour necrosis

Identifiers

PMID26021331
PMCPMC4518739

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.